Article ID Journal Published Year Pages File Type
5604315 International Journal of Cardiology 2017 16 Pages PDF
Abstract
Combination therapy of Ezetimibe (10 mg/day) and Simvastatin (40 mg/day) was more effective than mono-therapy with Simvastatin (40 mg/day) on reducing LDL-C, TG and hs-CRP level in percutaneous coronary intervention patients, leading to more significant anti-inflammatory effect.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
The effect of Ezetimibe and Simvastatin Combination Therapy on percutaneous coronary intervention patients
Authors
, ,